Home › Studies › PRJNA686835
PRJNA686835 SRP298654

Gut microbiota in lean/obese adults with T2D, Shanghai

Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D

Cross-sectional study of 182 gut metagenome samples from adult subjects in Shanghai, China, comparing lean and abdominally obese individuals with and without type 2 diabetes. machine-written summary

182 samples · 182 runs · CN · Adult · 2021 · 4.72 Gbp / sample · cohort Risk assessment with gut microbiome and metabolite

Sources
✓Sequence archive 1,638○Abstract / description✓Full text 364○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive1,638 sample values (collection date, country, health condition, health condition detail, latitude, location locality, location region, longitude)
○ Abstract / descriptionread; no usable statement
✓ Full text364 sample values (antibiotic exposure, location site) · PMC11730835, PMC12522779, PMC12763994, PMC8373164, PMC9746350
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 sampling locations · 1 country
Age
adult182
Condition
type2_diabetes78
healthy_control52
obesity52
Country
CN182
Body site
primary182
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 182 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 4.72 Gbp per sample0130Gbp
Community composition
Phocaeicola 20.0%Prevotella 17.4%Bacteroides 12.3%Faecalibacterium 4.9%Alistipes 3.8%Roseburia 3.2%Lachnospira 2.4%Parabacteroides 1.3%Acetatifactor 1.3%Ruminococcoides 1.1%Gemmiger 1.1%Enterocloster 1.0%not assigned to a genus 4.4%other genera 25.9%

Genera, mean relative abundance over 167 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category182 100%
country182 100%182
health_condition182 100%182
subject_id182 100%182
antibiotic_exposure182 100%182
collection_date182 100%182
detailed_location182 100%
health_condition_detail182 100%182
latitude182 100%182
location_locality182 100%182
location_region182 100%182
location_site182 100%182
longitude182 100%182
Papers (5)
  • Decreased Abundance of Akkermansia muciniphila Leads to the Impairment of Insulin Secretion and Glucose Homeostasis in Lean Type 2 Diabetes. 2021 PMID 34085773 PMC8373164 own_data
  • Risk assessment with gut microbiome and metabolite markers in NAFLD development. 2022 PMID 35675435 PMC9746350 unsure
  • Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease. 2025 PMID 39810263 PMC11730835 unsure
  • Characterization of the gut mycobiome in patients with non-alcoholic fatty liver disease and correlations with serum metabolome. 2025 PMID 41087898 PMC12522779 unsure
  • Characterization of the gut virome in patients with nonalcoholic fatty liver disease. 2025 PMID 41316248 PMC12763994 unsure
Details
Archive description

Numerous studies have revealed the association of gut microbiota to the development of two human metabolic disorders, obesity and type 2 diabetes (T2D). Medical research has found a positive correlation between the two diseases, and previous metagenomic studies have reported potential metagenomic markers linked with them. However, few metagenomic studies have been designed to investigate two related diseases interactively. Our objective here is to investigate how the gut microbiota contribute to the development and the differentiation of people into different metabolic status of obesity and T2D, by looking into 182 subjects from lean individuals with normal glucose tolerance (NL), abdominally obese individuals with normal glucose tolerance (NAO), lean individuals with T2D (TL) and abdominally obese individuals with T2D (TAO).

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by sonnet_x2 with confidence 0.75. Assay shotgun_dna.

  • host run.host_tax_id · “9606”
  • host study.title · “Human gut microbiota”
  • body site run.scientific_name · “gut metagenome”
  • body site study.title · “Human gut microbiota”
  • life stage study.description · “lean individuals with normal glucose tolerance”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN17126167antibiotic_exposurenoR30.70paper.fulltext.methodsantibiotic treatment within 3 months before sample collection
SAMN17126167collection_date2016-04R10.90biosample.attribute:collection_date2016-04
SAMN17126167countryCNR10.90sample.attr.geo_loc_nameChina: Shanghai
SAMN17126167health_conditionhealthy_controlR10.85biosample.attribute:descriptionNGT-lean (NL) group
SAMN17126167health_condition_detailNGT-lean (NL) groupR10.85biosample.attribute:descriptionNGT-lean (NL) group
SAMN17126167latitude31.1883R10.90biosample.attribute:lat_lon31.1883 N 121.4368 E
SAMN17126167location_localityShanghaiR10.85biosample.attribute:geo_loc_nameChina: Shanghai
SAMN17126167location_regionShanghai ShiR10.60biosample.attribute:lat_lon31.1883 N 121.4368 E
SAMN17126167location_siteShanghai Nicheng cohort studyR30.70paper.fulltext.methodsShanghai Nicheng cohort study
SAMN17126167longitude121.4368R10.90biosample.attribute:lat_lon31.1883 N 121.4368 E
SAMN17126167subject_idNL_104R10.70sample.name_rule:titleSubject ID NL_104 from NGT-lean (NL) group
Sequencing

182 runs over 182 samples · mean 4.76 Gbp per run (median 4.72 Gbp, total 866.64 Gbp; 182 runs with a base count) · layout PAIRED 182 · platform ILLUMINA 182 · models Illumina HiSeq 4000 (182) · 92% of runs with a Sandpiper profile · first public 2021-05-02

Authors (49)

Zhang J first · Ni Y · Qian L · Fang Q · Zheng T · Zhang M · Gao Q · Zhang Y · Ni J · Hou X · Bao Y · Kovatcheva-Datchary P · Xu A · Li H · Panagiotou G · Jia W last · Leung H first · Long X · Nychas E · Siliceo SL · Pohl D · Hanhineva K · Liu Y · Nielsen HB · Belda E · Clément K · Loomba R · Marfil-Sánchez A · Chen X · Mirhakkak M · Nieuwdorp M · Zheng N first · Wang D · Xing G · Gao Y · Li S · Liu J · Kang J · Sha S · Cheng L · Fan S · Yu J · Yan Q · Jiang C last · Wang L first · Liu M · Yuan Q · Chen H · Mao S

Downloads

PRJNA686835.csv.gz (5.8 KB) · parquet (78.7 KB) — all 182 samples, every field with route and confidence · PRJNA686835_determinations.csv.gz (14.5 KB) — 2,002 evidence rows

Samples (182 · every field this project has values for · hover a cell for its source)
Loading the sample table…